Enochian Biosciences, Inc.
ENOB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $2,819 | -$126,732 | $189 | -$7,252 |
| Dep. & Amort. | $42 | $33 | $32 | $32 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $181 | $898 | $1,499 | $559 |
| Change in WC | $0 | -$1,305 | $3,322 | -$2,017 |
| Other Non-Cash | -$4,391 | $125,296 | -$6,530 | $6,119 |
| Operating Cash Flow | -$1,349 | -$1,811 | -$1,487 | -$2,560 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $545 | $964 | -$1,464 | $0 |
| Investing Cash Flow | $545 | $964 | -$1,464 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $280 | -$280 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1,343 | $178 | $3,584 | $2,591 |
| Financing Cash Flow | $1,343 | $178 | $3,584 | $2,591 |
| Forex Effect | -$7 | -$162 | -$21 | $60 |
| Net Chg. in Cash | $532 | -$830 | $611 | $91 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $93 | $923 | $312 | $221 |
| End Cash | $625 | $93 | $923 | $312 |
| Free Cash Flow | -$1,349 | -$29,775,788 | $11,804,307,400 | -$2,560 |